Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Analysis of associations between CFS risk and mtDNA major haplogroups

From: Mitochondrial DNA variants correlate with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome

Haplogroup Case Control p value q value* Odds ratio 95 % CI
A 2 4 0.69 0.98 0.50 0.05 < OR < 3.56
B 2 2 1.00 1 1.02 0.07 < OR < 14.14
C 0 3 0.25 0.98
D 0 1 1.00 1
F 0 1 1.00 1
G 0 1 1.00 1
H 81 70 0.21 0.98 1.30 0.85 < OR < 2.00
I 4 7 0.54 0.98 0.57 0.12 < OR < 2.29
J 12 10 0.67 0.98 1.23 0.47 < OR < 3.27
K 20 15 0.38 0.98 1.39 0.65 < OR < 3.03
L 6 11 0.32 0.98 0.54 0.16 < OR < 1.63
M 2 1 0.62 0.98 2.04 0.11 < OR < 120.99
N 2 1 0.62 0.98 2.04 0.11 < OR < 120.99
R 1 0 0.50 0.98
T 14 28 0.03 0.6 0.47 0.22 < OR < 0.96
U 28 31 0.78 1 0.90 0.50 < OR < 1.63
V 6 3 0.33 0.98 2.06 0.43 < OR < 12.92
W 2 2 1.00 1 1.02 0.07 < OR < 14.14
X 4 2 0.45 0.98 2.05 0.29 < OR < 22.90
HV 7 3 0.22 0.98 2.42 0.54 < OR < 14.69
  1. *q values were calculated using the Benjamini–Hochberg method for correcting for multiple testing of haplogroups